Latest news
Dabur India moves court against FSSAI’s prohibition order - BusinessLineBusinessLine · Sun, 09 Aug 2026 10:54:59 GMTNovavax Hikes 2026 Revenue Outlook Despite 76% Q2 Revenue Decline - Medical DialoguesMedical Dialogues · Sat, 08 Aug 2026 14:41:31 GMTDabur Faces USFDA Warning Letter Over Falsified Records, CGMP Violations at Silvassa Facility - Medical DialoguesMedical Dialogues · Fri, 07 Aug 2026 17:05:11 GMTRelief for Dabur India: Delhi HC Stays FSSAI Ban on Products Carrying '100%' Claims - Medical DialoguesMedical Dialogues · Fri, 07 Aug 2026 14:45:39 GMT100% Pure Claim: Dabur Challenges FSSAI Order In Delhi High Court - Free Press JournalFree Press Journal · Fri, 07 Aug 2026 06:44:36 GMTDabur India Gets US FDA Warning for Silvassa Facility, Data Integrity - Storyboard18Storyboard18 · Fri, 07 Aug 2026 05:27:17 GMTStocks in Focus: Alkem Laboratories, J Kumar Infra, and Others - EquitypanditEquitypandit · Fri, 07 Aug 2026 03:34:00 GMTDabur receives US FDA warning letter for Silvassa plant; says issue limited to private label exports - CNBC TV18 - LinkedInLinkedIn · Thu, 06 Aug 2026 16:36:36 GMT